Literature DB >> 6183355

The interaction of human and rodent IgE with the human basophil IgE receptor.

D H Conrad, J R Wingard, T Ishizaka.   

Abstract

The cross-reactivity of the human IgE receptor with mouse and rat IgE was studied. Using leukocytes from a patient with chronic myelogenous leukemia, in which the mononuclear fraction contained up to 75% basophils, both rat and mouse IgE were found to inhibit the binding of 125I-human IgE to the human basophilic leukemia (HBL cells). About 15-fold more rodent IgE was required for 50% inhibition of binding than unlabeled human IgE (hIgE). Dose-response studies using increasing amounts of rodent vs human 125I-IgE indicated that the HBL cells had about 8000 receptors per cell for hIgE and 5500 receptors per cell for rodent IgE. When the HBL cells were surface labeled with 125I and subsequently solubilized with non-ionic detergent, the labeled hIgE receptor could be isolated by either affinity chromatography on IgE-Sepharose (either human or rodent) or by immunoprecipitation with hIgE and anti-IgE. By SDS-PAGE on 10% gels, the receptor had a m.w. of 58,000 daltons. The solubilized receptors exhibited some rebinding to hIgE-Sepharose, and this rebinding could be inhibited by either human or rodent IgE but not by human IgG. Both the HBL cells and normal human basophils could be passively sensitized with murine IgE anti-DNP for antigen-induced histamine release. The minimum concentration of the mouse IgE antibody for sensitizing normal basophils was 20 to 200 ng/ml. Pretreatment of basophils with human IgE, but not human IgG, abrogated the capacity of the murine IgE antibody to sensitize the cells for histamine release, which indicated that the human and rodent IgE were interacting with the same receptor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6183355

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Binding constants of IgE receptors on human blood basophils for IgE.

Authors:  J J Pruzansky; R Patterson
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

2.  A humanized mouse model of anaphylactic peanut allergy.

Authors:  Oliver T Burton; Amanda J Stranks; Jaciel M Tamayo; Kyle J Koleoglou; Lawrence B Schwartz; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2016-06-08       Impact factor: 10.793

Review 3.  Mechanisms of unpredictable adverse drug reactions.

Authors:  M J Rieder
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

4.  Suspension culture of human mast cells/basophils from umbilical cord blood mononuclear cells.

Authors:  M Ogawa; T Nakahata; A G Leary; A R Sterk; K Ishizaka; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

5.  Cells demonstrating Fc receptors for IgE.

Authors:  H Boltansky; M A Kaliner
Journal:  Surv Immunol Res       Date:  1984

6.  Interleukin 3 activates human blood basophils via high-affinity binding sites.

Authors:  P Valent; J Besemer; M Muhm; O Majdic; K Lechner; P Bettelheim
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 7.  Animal models for IgE-meditated cancer immunotherapy.

Authors:  Tracy R Daniels; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Cancer Immunol Immunother       Date:  2011-12-23       Impact factor: 6.968

8.  Formation of IgE-binding factors by human T-cell hybridomas.

Authors:  T F Huff; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Mapping of the high affinity Fc epsilon receptor binding site to the third constant region domain of IgE.

Authors:  A Nissim; M H Jouvin; Z Eshhar
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

10.  Cytokinergic IgE Action in Mast Cell Activation.

Authors:  Heather J Bax; Anthony H Keeble; Hannah J Gould
Journal:  Front Immunol       Date:  2012-08-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.